|Articles|May 1, 2000

Advances in the Treatment of GERD: A Managed Care Perspective
Volume 6
Issue 9 Suppl

A Critical Evaluation of Proton Pump Inhibitors in the Treatment of Gastroesophageal Reflux Disease

Author(s)Rosemary R. Berardi, PharmD, FASHP

Download PDF: A Critical Evaluation of Proton Pump Inhibitors in the Treatment of Gastroesophageal Reflux Disease

Articles in this issue

about 26 years ago

Article

Participating Faculty

about 26 years ago

Article

Introduction

about 26 years ago

Article

An Overview of Gastroesophageal Reflux Disease

about 26 years ago

Article

New Therapeutic Options in the Treatment of Gastroesophageal Reflux Disease and Other Acid-Peptic Diseases

about 26 years ago

Article

Guidelines for the Diagnosis and Treatment of Gastroesophageal Reflux Disease

about 26 years ago

Article

Treatment of Gastroesophageal Reflux Disease in a Managed Care Environment

about 26 years ago

Article

Roundtable Discussion

about 26 years ago

Article

Selected Abstracts

about 26 years ago

Article

Continuing Medical/Pharmacy Education Quiz

about 26 years ago

Article

Bibliography

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

US map with stethoscope | Image Credit: © Andreas Prott - stock.adobe.com

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

ByShifeng Wu, MM

June 5th 2026

Health Care Utilization in Veterans With Alzheimer Disease

ByYing Wang, PhD,Byron J. Aguilar, PhD,Mingfei Li, PhD,Peter Morin, MD, PhD,Joel Reisman, BS,Wen Hu, MS,Jong Soo Lee, PhD,Dan Berlowitz, MD, MPH,Qinqing Li, MS,Raymond Zhang, PhD,Amir Abbas Tahami Monfared, MD, PhD,Quanwu Zhang, PhD,Weiming Xia, PhD

June 4th 2026

Health care costs | Image Credit: © Valeri Luzina - stock.adobe.com

What Do We Do With These Prices? Ushering in the Next Phase of Price Transparency Innovation in Medicare Advantage

ByPooja Chandrashekar, MD, MBA,Sachin H. Jain, MD, MBA

June 4th 2026

Real-World Weight Loss With Injectable Semaglutide vs Dulaglutide for Diabetes

ByAllison Spitery, PharmD, BCACP,Alison Lobkovich, PharmD, BCACP,Emily Thomas, PharmD, BCPS, BCACP

June 4th 2026

Orthopedic surgeon holds bone x-ray | Image Credit: © tippapatt - stock.adobe.com

Musculoskeletal Quality Collaborative Improves Value-Based Health Care Delivery Across Hospital System

ByHannah I. Travers, MD,Mikhail Kuznetsov, MD,John Mazzocco, MD,Nicholas Pagani, MD,Tricia Ide, DNP, RN,Brian L. Hollenbeck, MD,Eric L. Smith, MD

June 3rd 2026

A Critical Evaluation of Proton Pump Inhibitors in the Treatment of Gastroesophageal Reflux Disease

Articles in this issue

Related Content

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

Health Care Utilization in Veterans With Alzheimer Disease

What Do We Do With These Prices? Ushering in the Next Phase of Price Transparency Innovation in Medicare Advantage

Real-World Weight Loss With Injectable Semaglutide vs Dulaglutide for Diabetes

Musculoskeletal Quality Collaborative Improves Value-Based Health Care Delivery Across Hospital System

Trending on AJMC

Three Years on Baricitinib Preserved Hair Regrowth in Severe Alopecia Areata

Oz White House Briefing Touts Drug Savings and Fraud Cleanup, but Data Tell a Nuanced Story

Plastic in Personal Care Products Tied to Skin Disease and Environmental Pollution, Review Finds

Endometriosis Reduces Ovarian Reserve via Inflammation and Surgery

Black-White NSCLC Survival Gap Widens in Counties With Greater Racial Inequity